Works by Marty, Michel

Results: 29

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors.

Published in:

OncoImmunology, 2014, v. 3, n. 5, p. N.PAG, doi. 10.4161/onci.28782

By:

Achour, Abla;
Baychelier, Florence;
Marty, Michel;
Debré, Patrice;
Samuel, Didier;
Vieillard, Vincent

Publication type:

Article

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin--Cyclophosphamide Regimen.

Published in:

PLoS Medicine, 2007, v. 4, n. 3, p. 0585, doi. 10.1371/journal.pmed.0040090

By:

Bertheau, Philippe;
Turpin, Elisabeth;
Rickman, David S.;
Espie, Marc;
Reyniés, Aurélien;
Feugeas, Jean-Paul;
Plassa, Louis-François;
Soliman, Hany;
Varna, Mariana;
De Roquancourt, Anne;
Lehmann-Che, Jacqueline;
Beuzard, Yves;
Marty, Michel;
Misset, Jean-Louis;
Janin, Anne;
De Thé, Hugues

Publication type:

Article

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients.

Published in:

BMC Cancer, 2011, v. 11, n. 1, p. 215, doi. 10.1186/1471-2407-11-215

By:

de Cremoux, Patricia;
Valet, Fabien;
Gentien, David;
Lehmann-Che, Jacqueline;
Scott, Véronique;
Tran-Perennou, Carine;
Barbaroux, Catherine;
Servant, Nicolas;
Vacher, Sophie;
Sigal-Zafrani, Brigitte;
Mathieu, Marie-Christine;
Bertheau, Philippe;
Guinebretière, Jean-Marc;
Asselain, Bernard;
Marty, Michel;
Spyratos, Frédérique

Publication type:

Article

NF-kappa B genes have a major role in inflammatory breast cancer.

Published in:

2008

By:

Lerebours F;
Vacher S;
Andrieu C;
Espie M;
Marty M;
Lidereau R;
Bieche I;
Lerebours, Florence;
Vacher, Sophie;
Andrieu, Catherine;
Espie, Marc;
Marty, Michel;
Lidereau, Rosette;
Bieche, Ivan

Publication type:

journal article

NF-kappa B genes have a major role in Inflammatory Breast Cancer.

Published in:

BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-41

By:

Lerebours, Florence;
Vacher, Sophie;
Andrieu, Catherine;
Espie, Marc;
Marty, Michel;
Lidereau, Rosette;
Bieche, Ivan

Publication type:

Article

Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?

Published in:

2008

By:

Debourdeau P;
Elalamy I;
de Raignac A;
Meria P;
Gornet JM;
Amah Y;
Korte W;
Marty M;
Farge D;
Debourdeau, Philippe;
Elalamy, Ismail;
de Raignac, Axelle;
Meria, Paul;
Gornet, Jean Marc;
Amah, Yahovi;
Korte, Wolfang;
Marty, Michel;
Farge, Dominique

Publication type:

journal article

Chloé me manque, Chloé nous manque.

Published in:

Oncologie (Tech Science Press), 2005, v. 7, n. 5, p. 337, doi. 10.1007/s10269-005-0241-x

By:

Marty, Michel

Publication type:

Article

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Published in:

2013

By:

Groheux, David;
Hatt, Mathieu;
Hindié, Elif;
Giacchetti, Sylvie;
de Cremoux, Patricia;
Lehmann-Che, Jacqueline;
Martineau, Antoine;
Marty, Michel;
Cuvier, Caroline;
Cheze-Le Rest, Catherine;
de Roquancourt, Anne;
Visvikis, Dimitris;
Espié, Marc

Publication type:

journal article

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors.

Published in:

Cancer (0008543X), 2013, v. 119, n. 11, p. 1960, doi. 10.1002/cncr.28020

By:

Groheux, David;
Hatt, Mathieu;
Hindié, Elif;
Giacchetti, Sylvie;
de Cremoux, Patricia;
Lehmann‐Che, Jacqueline;
Martineau, Antoine;
Marty, Michel;
Cuvier, Caroline;
Cheze‐Le Rest, Catherine;
de Roquancourt, Anne;
Visvikis, Dimitris;
Espié, Marc

Publication type:

Article

Distinct tumor protein p53 mutants in breast cancer subgroups.

Published in:

International Journal of Cancer, 2013, v. 132, n. 5, p. 1227, doi. 10.1002/ijc.27767

By:

Dumay, Anne;
Feugeas, Jean‐Paul;
Wittmer, Evelyne;
Lehmann‐Che, Jacqueline;
Bertheau, Philippe;
Espié, Marc;
Plassa, Louis‐François;
Cottu, Paul;
Marty, Michel;
André, Fabrice;
Sotiriou, Christos;
Pusztai, Lajos;
de Thé, Hugues

Publication type:

Article

Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.

Published in:

1984

By:

Ferme, Christophe;
Teillet, Francois;
D'Agay, Marie-Francoise;
Gisselbrecht, Christian;
Marty, Michel;
Boiron, Michel;
Ferme, C;
Teillet, F;
d'Agay, M F;
Gisselbrecht, C;
Marty, M;
Boiron, M

Publication type:

journal article

Promyelocytic blast crisis of chronic myelocytic leukemia with both t(9;22) and t(15;17) in M3 cells.

Published in:

1984

By:

Castaigne, Sylvie;
Berger, Roland;
Jolly, Veronique;
Daniel, Marie Therese;
Bernheim, Alain;
Marty, Michel;
Degos, Laurent;
Flandrin, Georges;
Castaigne, S;
Berger, R;
Jolly, V;
Daniel, M T;
Bernheim, A;
Marty, M;
Degos, L;
Flandrin, G

Publication type:

journal article

Fluorouracil (F), Adriamycin (A), and cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma.

Published in:

1983

By:

Gisselbrecht, Christian;
Calvo, Fabien;
Mignot, Laurent;
Pujade, Eric;
Bouvry, Michel;
Danne, Odile;
Belpomme, Dominique;
Marty, Michel;
Gisselbrecht, C;
Calvo, F;
Mignot, L;
Pujade, E;
Bouvry, M;
Danne, O;
Belpomme, D;
Marty, M

Publication type:

journal article

Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.

Published in:

Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 249, doi. 10.2967/jnumed.111.094045

By:

Groheux, David;
Hindié, Elif;
Giacchetti, Sylvie;
Delord, Marc;
Hamy, Anne-Sophie;
de Roquancourt, Anne;
Vercellino, Laetitia;
Berenger, Nathalie;
Marty, Michel;
Espié, Marc

Publication type:

Article

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.

Published in:

Oncogene, 2002, v. 21, n. 49, p. 7593, doi. 10.1038/sj.onc.1205932

By:

Turpin, Elizabeth;
Bieche, Ivan;
Bertheau, Philippe;
Plassa, Louis-Francois;
Lerebours, Florence;
Roquancourt, Anne de;
Olivi, Martine;
Espie, Marc;
Marty, Michel;
Lidereau, Rosette;
Vidaud, Michel;
The, Hughes de

Publication type:

Article

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.

Published in:

Oncogene, 1999, v. 18, n. 54, p. 7834, doi. 10.1038/sj.onc.1203196

By:

Turpin, Elisabeth;
Dalle, Bruno;
de Roquancourt, Anne;
Plassa, L François;
Marty, Michel;
Janin, Anne;
Beuzard, Yves;
de Thé, Hugues

Publication type:

Article

1052. In Vivo Repopulation Ability of Genetically Corrected Bone Marrow Cells from Fanconi Anemia Patients.

Published in:

Molecular Therapy, 2006, v. 13, p. S403, doi. 10.1016/j.ymthe.2006.08.1148

By:

Cohen-Haguenauer, Odile;
Peault, Bruno;
Bauche, Cécile;
Daniel, Marie-Thérèse;
Casal, Ibrahim;
Levy, Vincent;
Dausset, Jean;
Boiron, Michel;
Auclair, Christian;
Gluckman, Eliane;
Marty, Michel

Publication type:

Article

European Medicines Agency Review of Ofatumumab (ArzerraÂ®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...

Published in:

2010

By:

Gravanis, Iordanis;
ErsbÃ¸ll, Jens;
Skovlund, Eva;
Abadie, Eric;
Marty, Michel;
Pignatti, Francesco

Publication type:

Journal Article

European Medicines Agency Review of Ofatumumab (Arzerra©) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...

Published in:

Oncologist, 2010, v. 15, n. 12, p. 1335, doi. 10.1634/theoncologist.2010-0255

By:

GRAVANIS, IORDANIS;
ERSBLL, JENS;
SKOVLUND, EVA;
ABADIE, ERIC;
MARTY, MICHEL;
PIGNATTI, FRANCESCO

Publication type:

Article

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers.

Published in:

Oncologist, 2010, v. 15, n. 3, p. 246, doi. 10.1634/theoncologist.2009-0243

By:

Lehmann-Che, Jacqueline;
André, Fabrice;
Desmedt, Christine;
Mazouni, Chafika;
Giacchetti, Sylvie;
Turpin, Elisabeth;
Espié, Marc;
Plassa, Louis-François;
Marty, Michel;
Bertheau, Philippe;
Sotiriou, Christos;
Piccart, Martine;
Symmans, W. Fraser;
Pusztai, Lajos;
de Thé, Hugues

Publication type:

Article

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.

Published in:

International Journal of Breast Cancer, 2013, p. 1, doi. 10.1155/2013/130470

By:

Bidard, François-Clément;
Belin, Lisa;
Delaloge, Suzette;
Lerebours, Florence;
Ngo, Charlotte;
Reyal, Fabien;
Alran, Séverine;
Giacchetti, Sylvie;
Marty, Michel;
Lebofsky, Ronald;
Pierga, Jean-Yves

Publication type:

Article

Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer.

Published in:

2012

By:

Spyratos, Frédérique;
Valet, Fabien;
Bièche, Ivan;
Scott, Véronique;
Lehmann-Che, Jacqueline;
Asselain, Bernard;
Tembo, Olivier;
Marty, Michel;
Cremoux, Patricia

Publication type:

Letter

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.

Published in:

Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 429, doi. 10.1007/s10549-010-0939-3

By:

Pierga, Jean-Yves;
Delaloge, Suzette;
Espié, Marc;
Brain, Etienne;
Sigal-Zafrani, Brigitte;
Mathieu, Marie-Christine;
Bertheau, Philippe;
Guinebretière, Jean;
Spielmann, Marc;
Savignoni, Alexia;
Marty, Michel

Publication type:

Article

Introduction.

Published in:

Oncology, 1994, v. 51, n. S1, p. 1, doi. 10.1159/000227406

By:

Marty, Michel E.

Publication type:

Article

Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.

Published in:

Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 3, p. 249, doi. 10.1038/clpt.1992.19

By:

Canal, Pierre;
Robert, Jacques;
Ramon, Marianne;
Baurain, Roger;
Tresca, Patricia;
de Forni, Marcel;
Marty, Michel;
Pujade-Lauraine, Eric;
Bugat, Roland;
Magis, Alex;
Belpomme, Dominique

Publication type:

Article

Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study.

Published in:

Diabetes Care, 2014, v. 37, n. 1, p. 134, doi. 10.2337/dc13-0695

By:

Grimaldi-Bensouda, Lamiae;
Cameron, David;
Marty, Michel;
Barnett, Anthony H.;
Penault-Llorca, Frédérique;
Pollak, Michael;
Charbonnel, Bernard;
Riddle, Matthew;
Mignot, Laurent;
Boivin, Jean-François;
Khachatryan, Artak;
Rossignol, Michel;
Bénichou, Jacques;
Alpérovitch, Annick;
Abenhaim, Lucien

Publication type:

Article

Phase I and pharmacokinetic study of etaracizumab (Abegrinâ¢), a humanized monoclonal antibody against Î±vÎ²3 integrin receptor, in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2008, v. 26, n. 1, p. 35, doi. 10.1007/s10637-007-9077-0

By:

Catherine Delbaldo;
Eric Raymond;
Karina Vera;
Luz Hammershaimb;
Karen Kaucic;
Michel Marty

Publication type:

Article

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.

Published in:

Journal of Pathology, 2001, v. 194, n. 4, p. 413, doi. 10.1002/path.902

By:

Ma, Lin;
de Roquancourt, Anne;
Bertheau, Philippe;
Chevret, Sylvie;
Millot, Guy;
Sastre-Garau, Xavier;
Espié, Marc;
Marty, Michel;
Janin, Anne;
Calvo, Fabien

Publication type:

Article

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Published in:

International Journal of Cancer, 2002, v. 102, n. 6, p. 618, doi. 10.1002/ijc.10729

By:

Lerebours, Florence;
Bertheau, Philippe;
Bieche, Ivan;
Driouch, Keltouma;
de The, Hugues;
Hacene, Kamel;
Espie, Marc;
Marty, Michel;
Lidereau, Rosette

Publication type:

Article

Works by Marty, Michel

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors.

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin--Cyclophosphamide Regimen.

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients.

NF-kappa B genes have a major role in inflammatory breast cancer.

NF-kappa B genes have a major role in Inflammatory Breast Cancer.

Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?

Chloé me manque, Chloé nous manque.

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors.

Distinct tumor protein p53 mutants in breast cancer subgroups.

Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.

Promyelocytic blast crisis of chronic myelocytic leukemia with both t(9;22) and t(15;17) in M3 cells.

Fluorouracil (F), Adriamycin (A), and cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma.

Triple-Negative Breast Cancer: Early Assessment with <sup>18</sup>F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.

1052. In Vivo Repopulation Ability of Genetically Corrected Bone Marrow Cells from Fanconi Anemia Patients.

European Medicines Agency Review of Ofatumumab (ArzerraÂ®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...

European Medicines Agency Review of Ofatumumab (Arzerra©) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers.

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.

Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer.

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.

Introduction.

Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.

Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study.

Phase I and pharmacokinetic study of etaracizumab (Abegrinâ¢), a humanized monoclonal antibody against Î±<sub>v</sub>Î²<sub>3</sub> integrin receptor, in patients with advanced solid tumors.

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.